SCHEMBL461357

SCHEMBL461357

O=C(NO)C1=CCc2ccccc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 6/20 0.42
▸ HDAC6 Q9UBN7 5/20 0.42
▸ HDAC1 Q13547 5/20 0.42
▸ HDAC2 Q92769 4/20 0.42
▸ HDAC7 Q8WUI4 3/20 0.42
▸ HDAC3 O15379 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ NCOR2 Q9Y618 1/20 0.42
▸ HDAC4 P56524 3/20 0.41
▸ HDAC5 Q9UQL6 2/20 0.41
▸ PLD2 O14939 1/20 0.40
▸ PLD1 Q13393 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ MPO P05164 1/20 0.38
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131373 0.80 CYP1A2 (0.39) ALOX15PLD2PLD1KDM4ECYP1A2
SCHEMBL30640267 0.80 CYP1A2 (0.39) ALOX15PLD2PLD1KDM4ECYP1A2
SCHEMBL31548709 0.73 CYP1A2 (0.33) PLD2PLD1KDM4ESMN1; SMN2CYP1A2
Acetohydroxamic Acid SCHEMBL28905392 0.69 HDAC7 (0.52) HDAC8HDAC6HDAC1HDAC2HDAC7
Hydroxyurea SCHEMBL8687113 0.69 HDAC7 (0.52) HDAC8HDAC6HDAC1HDAC2HDAC7
SCHEMBL15821065 0.67 HDAC6 (0.44) HDAC8HDAC6HDAC1HDAC2HDAC7
SCHEMBL20793908 0.66 HCAR2 (0.43) HSD17B10KDM4E
SCHEMBL2521301 0.66 CYP1A2 (0.46) CA1ALOX15HSD17B10CYP1A2
SCHEMBL1143178 0.66 CYP1A2 (0.40) CA1ALOX15HSD17B10GAACYP1A2
SCHEMBL260496 0.65 NOTUM (0.39) HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2613775-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-07-17 — — EP disclosed
WO-2012031993-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 — — WO disclosed
Send feedback